Company Filing History:
Years Active: 2024
Title: Yunggeun Choi: Innovator in Rho-Kinase Inhibition
Introduction
Yunggeun Choi is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of selective inhibitors for Rho-kinases. His work has implications for various therapeutic applications.
Latest Patents
Yunggeun Choi holds a patent for "Selective inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof." This invention relates to novel substituted bicyclic derivatives that can inhibit Rho-kinases and/or Rho-kinase mediated phosphorylation of myosin light chain phosphates. The patent also covers compositions comprising these derivatives, methods for preparing them, and methods for their use.
Career Highlights
Choi is currently associated with Genosco, where he continues to advance his research and development efforts. His innovative work in the field of protein kinases has positioned him as a key figure in biopharmaceutical research.
Collaborations
Some of his notable coworkers include Wongil Lee and William G Devine. Their collaborative efforts contribute to the ongoing research and development initiatives at Genosco.
Conclusion
Yunggeun Choi's contributions to the field of biochemistry through his patent on Rho-kinase inhibitors highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.